Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06547320 · ClinicalTrials.gov registry record · Phase 2
Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior
A Phase 2 study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT06547320: Completed Phase 2 study, sponsored by The Miriam Hospital.
NCT06547320 is a Phase 2 study that has completed, run by The Miriam Hospital. The registered enrollment target is 43 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06547320, a Phase 2 study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a sensor device called an Automatic Ingestion Monitor (AIM) that is worn on eyeglasses can be used with a smartphone to change eating behavior. Participants will wear the device for one week of no-intervention observation. They will then test behavioral interventions focused on eating for two weeks. The researchers hypothesize that messages sent to a smartphone that are based on information from the AIM can reduce the amount of food that is eaten and slow eating.
Primary Outcome
Total amount of energy consumed from foods and beverages
Interventions
- BEHAVIORAL Eat Less Intervention
- BEHAVIORAL Eat Slower Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2025-05-30 |
| Phase | Phase 2 |
What the finished NCT06547320 record still lists
NCT06547320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Eat Less Intervention is the first listed.
NCT06547320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06547320 about?
NCT06547320 is a clinical study titled "Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior". The purpose of this study is to determine whether a sensor device called an Automatic Ingestion Monitor (AIM) that is worn on eyeglasses can be used with a smartphone to change eating behavior. Participants will wear the device for one week of no-intervention observation. They will then test behavio...
What is the current status of trial NCT06547320?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2025-01-01. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT06547320?
The interventions under investigation include: Eat Less Intervention (BEHAVIORAL), Eat Slower Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06547320?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06547320's enrollment target sits among peer trials
43 1332nd of 2000 higher than 662 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI